Editorial
doi: 10.1161/CIRCULATIONAHA.113.006928.
Epub 2013 Dec 9.
Smoking cessation: benefits versus risks of using pharmacotherapy to quit
Affiliations
- PMID: 24323794
- PMCID: PMC3917568
- DOI: 10.1161/CIRCULATIONAHA.113.006928
Item in Clipboard
Editorial
Smoking cessation: benefits versus risks of using pharmacotherapy to quit
Circulation.
.
No abstract available
Keywords: Editorials; pharmacology; smoking; smoking cessation.
Conflict of interest statement
Comment on
-
Cardiovascular events associated with smoking cessation pharmacotherapies: a network meta-analysis.Circulation. 2014 Jan 7;129(1):28-41. doi: 10.1161/CIRCULATIONAHA.113.003961. Epub 2013 Dec 9. Circulation. 2014. PMID: 24323793 Free PMC article.
Similar articles
-
Network meta-analysis demonstrates the safety of pharmacotherapy for smoking cessation in cardiovascular patients.Evid Based Med. 2014 Oct;19(5):193. doi: 10.1136/eb-2014-110030. Epub 2014 Jun 4. Evid Based Med. 2014. PMID: 24917603 No abstract available.
-
ACP Journal Club. Review: Nicotine replacement therapy increases CVD events; bupropion and varenicline do not.Ann Intern Med. 2014 Apr 15;160(8):JC2. doi: 10.7326/0003-4819-160-8-201404150-02002. Ann Intern Med. 2014. PMID: 24733219 No abstract available.
-
The risk of adverse cardiovascular events from varenicline balanced against the benefits in mortality from smoking cessation.Nicotine Tob Res. 2012 Dec;14(12):1391-3. doi: 10.1093/ntr/nts028. Epub 2012 Mar 15. Nicotine Tob Res. 2012. PMID: 22422928 No abstract available.
-
Nicotine receptor partial agonists for smoking cessation.Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6. Cochrane Database Syst Rev. 2012. Update in: Cochrane Database Syst Rev. 2016 May 09;(5):CD006103. doi: 10.1002/14651858.CD006103.pub7. PMID: 22513936 Updated. Review.
-
Nicotine receptor partial agonists for smoking cessation.Cochrane Database Syst Rev. 2011 Feb 16;(2):CD006103. doi: 10.1002/14651858.CD006103.pub5. Cochrane Database Syst Rev. 2011. Update in: Cochrane Database Syst Rev. 2012 Apr 18;(4):CD006103. doi: 10.1002/14651858.CD006103.pub6. PMID: 21328282 Updated. Review.
Cited by
-
The Role of Antioxidants Supplementation in Clinical Practice: Focus on Cardiovascular Risk Factors.Antioxidants (Basel). 2021 Jan 20;10(2):146. doi: 10.3390/antiox10020146. Antioxidants (Basel). 2021. PMID: 33498338 Free PMC article. Review.
References
-
- U.S. Department of Health and Human Services. The health benefits of smoking cessation. A report of the Surgeon General. Washington, D.C: U.S. Department of Health and Human Services, Public Health Service, Office on Smoking and Health; 1990.
-
- U.S. Department of Health and Human Services. The health consequences of smoking. A report of the Surgeon General. Washington, D.C: U.S. Department of Health and Human Services, Public Health Service, Office on Smoking and Health; 2004.
-
- U.S. Preventive Services Task Force. Counseling and Interventions to Prevent Tobacco Use and Tobacco-Caused Disease in Adults and Pregnant Women: Reaffirmation Recommendation Statement. Rockville: Agency for Healthcare Research and Quality; Apr, 2009. - PubMed
-
- World Health Organization. WHO report on the global tobacco epidemic, 2008: the MPOWER package. Geneva: World Health Organization; 2008.
-
- Centers for Disease Control and Prevention. Quitting smoking among adults--United States, 2001–2010. MMWR Morb Mortal Wkly Rep. 2011;60:1513–1519. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
